Dr. Rășanu Alina

Rheumatology
Internal Medicine
in contract with CASMB for the specialty Internal Medicine

Choose Internal Medicine Integrative Medicine

In order to benefit from a medical service settled by CASMB, a referral from the family doctor or a doctor who is under contract with CASMB is required.

Request an appointment

After completing this form, you will be contacted by a representative of the ImunoMedica clinic to set up an appointment with the doctor and the desired specialty.

All fields marked with * are mandatory

Personal data

Send

2011
Senior Doctor Rheumatology - "Carol Davila" University of Medicine, Bucharest

2010
Specialist Doctor Internal Medicine - "Carol Davila" University of Medicine, Bucharest

2008
PhD in Internal Medicine with " Digestive manifestations in collagen diseases" - at "Cantacuzino Hospital" with prof. V. Stoica , Bucharest

2007
Medical residency in Internal medicine at Cantacuzino Hospital, Bucharest

2006
Specialist Doctor Rheumatology - "Carol Davila" Univerity of Medicine, Bucharest

2003
Start the study for " Digestive manifestations in collagen diseases" at " Cantacuzino Hospital" with prof. Dr. V. Stoica, Bucharest

2002
Rheumatology residency at Cantacuzino Hospital, Bucharest

2000
Graduated from University of Medicine "Carol Davila"- Bucharest, Romania

2007
Sonography

2007
Musculoskeletal ultrasound

2006
Bone densitometry

2007- present
Senior Doctor Rheumatology and Specialist Doctor Internal Medicine, Cantacuzino Hospital- Department of Rheumatology and Internal Medicine, Bucharest, Romania

2004-2006
Chef Resident Cantacuzino Hospital -Departament of Rheumatology, Bucharest, Romania

2003-2004
Senior Resident Filantropia Hospital -Departament of Medical Rehabilitation, Bucharest, Romania

2002-2003
Junior Resident Cantacuzino Hospital- Departament of Internal Medicine, Bucharest, Romania

2001-2002 Intern - Sf. Ioan Hospital –Departament of Intesive Care, , Bucharest, Romania

Jan 2014- March 2015
T2T study prospective study in early rheumatoid arthritis patients with active disease to evaluate the efficacy and safety of methotrexate – investigator

Feb-Sep 2013
Orion Study, prospective study with 1400 patients diagnosed with osteoporosis to evaluate the efficacy and safety of Strontium Ranelate therapy - sub-investigator

2012
Multicenter, non-comparative, open-label study to evaluate the efficacy and safety of MabThera therapy in patients with active rheumatoid arthritis who had an inadequate response to an antiTNF agent - Program Fast 2 switch - 500 patients - investigator

Oct-Nov 2011
Diagnostic study. 1800 patients diagnosed with osteoporosis for the evaluation of therapy with Strontium Ranelate - subinvestigator

2009
Post-marketing study of MabThera prescribed in patients with TNF-IR to evaluate the efficacy and safety of repeated treatments in routine clinical practice (REPEAT), ML 25228 - 200 patient study - investigator